| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1078-0432.CCR-08-0953 |
| P698 | PubMed publication ID | 19118029 |
| P50 | author | Carsten Müller-Tidow | Q23564829 |
| Hubert Serve | Q39186141 | ||
| Steffen Koschmieder | Q49505610 | ||
| Marc Hotfilder | Q91781149 | ||
| P2093 | author name string | Volker Gerke | |
| Martin Dugas | |||
| Utz Krug | |||
| Wolfgang E Berdel | |||
| Antje Hascher | |||
| Claus Kerkhoff | |||
| Rolf M Mesters | |||
| Markus Knop | |||
| Bülent Sargin | |||
| Alessandro Marra | |||
| Ruediger Liersch | |||
| Yu Jun | |||
| Etmar Bulk | |||
| P2860 | cites work | A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. | Q34555834 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 22-29 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | S100A2 induces metastasis in non-small cell lung cancer | |
| P478 | volume | 15 |
| Q35337546 | A multiplexed, targeted mass spectrometry assay of the S100 protein family uncovers the isoform-specific expression in thyroid tumours |
| Q87633847 | Activation of hedgehog signaling pathway in human non-small cell lung cancers |
| Q46783208 | Clinical significance of S100A2 expression in gastric cancer |
| Q35591343 | Comparative Proteomic Analysis of Human Cholangiocarcinoma Cell Lines: S100A2 as a Potential Candidate Protein Inducer of Invasion |
| Q33860486 | Comparative genomic analyses identify common molecular pathways modulated upon exposure to low doses of arsenic and cadmium |
| Q37851511 | Could serum measurements of S100 proteins be reliable markers to predict recurrence in meningiomas? |
| Q33771159 | DNA methylation in glioblastoma: impact on gene expression and clinical outcome |
| Q97523116 | Development and validation of a hypoxia-related gene signature to predict overall survival in early-stage lung adenocarcinoma patients |
| Q51596002 | Diagnostic significance of S100A2 and S100A6 levels in sera of patients with non-small cell lung cancer. |
| Q37554595 | Distinct prognostic values of S100 mRNA expression in breast cancer |
| Q34101059 | Emerging lung cancer therapeutic targets based on the pathogenesis of bone metastases |
| Q37615626 | Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies |
| Q38723380 | Exhaled breath condensate biomarkers for the early diagnosis of lung cancer using proteomics. |
| Q64086388 | Expression profile and functional role of S100A14 in human cancer |
| Q37620999 | Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters |
| Q35217663 | Heterogeneity research in muscle-invasive bladder cancer based on differential protein expression analysis |
| Q38435063 | Impact of somatic copy number alterations on the glioblastoma miRNome: miR-4484 is a genomically deleted tumour suppressor. |
| Q36006961 | Involvement of S100A14 protein in cell invasion by affecting expression and function of matrix metalloproteinase (MMP)-2 via p53-dependent transcriptional regulation |
| Q38118075 | Joining S100 proteins and migration: for better or for worse, in sickness and in health. |
| Q39638783 | Lack of modulatory function of coding nucleotide polymorphism S100A2_185G>A in oral squamous cell carcinoma |
| Q57422493 | Molecular diagnostics in pancreatic cancer |
| Q57181491 | Multiple S100 protein isoforms and C-terminal phosphorylation contribute to the paralog-selective regulation of nonmuscle myosin 2 filaments |
| Q42128457 | Novel interactions of the TRTK12 peptide with S100 protein family members: specificity and thermodynamic characterization |
| Q37046492 | Osteoactivin (GPNMB) ectodomain protein promotes growth and invasive behavior of human lung cancer cells |
| Q90486716 | Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer |
| Q38871014 | Phosphorylation of interleukin (IL)-24 is required for mediating its anti-cancer activity |
| Q52614372 | Prognostic Roles of mRNA Expression of S100 in Non-Small-Cell Lung Cancer. |
| Q50543875 | Prognostic impact of S100A9 overexpression in non-small cell lung cancer. |
| Q35072838 | Prognostic significance of cytoplasmic S100A2 overexpression in oral cancer patients. |
| Q36425962 | Prognostic significance of different immunohistochemical S100A2 protein expression patterns in patients with operable nonsmall cell lung carcinoma |
| Q60044321 | Prognostic values of S100 family members in ovarian cancer patients |
| Q39101381 | Protumorigenic actions of S100A2 involve regulation of PI3/Akt signaling and functional interaction with Smad3. |
| Q39322616 | Regulation of S100A2 expression by TGF-β-induced MEK/ERK signalling and its role in cell migration/invasion. |
| Q38689543 | Retrospective Proteomic Screening of 100 Breast Cancer Tissues. |
| Q37650123 | S100 protein family in human cancer |
| Q35206368 | S100 proteins in cancer |
| Q96576801 | S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1 |
| Q35758021 | S100A14, a mediator of epithelial-mesenchymal transition, regulates proliferation, migration and invasion of human cervical cancer cells. |
| Q37762477 | S100A2 in cancerogenesis: a friend or a foe? |
| Q39451596 | S100A2 promoter-driven conditionally replicative adenovirus targets non-small-cell lung carcinoma |
| Q38215158 | S100A2 protein and non-small cell lung cancer. The dual role concept. |
| Q92939138 | S100B as an Antagonist To Interfere with the Interface Area Flanked by S100A11 and RAGE V Domain |
| Q37707574 | Systematic analysis of mRNA expression profiles in NSCLC cell lines to screen metastasis-related genes |
| Q60054767 | TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma |
| Q38880716 | Targeted inhibition of genome-wide DNA methylation analysis in epigenetically modulated phenotypes in lung cancer |
| Q42481244 | The role of S100 genes in breast cancer progression |
| Q33976905 | The role of S100A14 in epithelial ovarian tumors. |
Search more.